Evidence map›Paper›PMID 42644127›Full record

ArticleClinicoEconomics and outcomes research : CEOR2026

What to Expect in 2026-2027: Important Health Economics and Outcomes Research Topics.

Ivo Abraham, Mickael Hiligsmann, Kenneth K C Lee, Giorgio L Colombo, Leslie Citrome, Mike Gregg

Abstract readEditorial
In one paragraph

Article in ClinicoEconomics and outcomes research : CEOR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ivo AbrahamUniversity of Arizona, Tucson, AZ, USA.
Mickael HiligsmannMaastricht University, Maastricht, the Netherlands.
Kenneth K C LeeMonash University, Subang Jaya, Selangor, Malaysia.
Giorgio L ColomboUniversity of Pavia, Department of Drug Sciences, Pavia, Italy.ORCID 0000-0002-5790-8891
Leslie CitromeNew York Medical College, Valhalla, NY, USA.ORCID 0000-0002-6098-9266
Mike GreggTaylor & Francis, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An infographic titled 'What to Expect in 2026-2027: Important Health Economics and Outcomes Research (HEOR) Topics' outlines five key HEOR areas. 1. HEOR Models: AI is transforming HEOR with advanced data, but needs validation to avoid errors. 2. Real World Evidence: Essential in healthcare, it connects clinical trials with real-life practice for improved access and regulation. 3. Prevention Economics: Now a policy focus, showing that investing in prevention is financially crucial for effective implementation. 4. Health Equity: Involves expanding access, integrating social determinants and developing methods to measure healthcare impact. 5. Healthcare Resource Reallocation: Spending is shifting from austerity to resilience, emphasizing prevention for better fiscal outcomes than defense spending. The infographic includes decorative elements.An infographic listing top five HEOR topics for 2026-2027, numbered 1 to 5 with headings and summaries.

Identifiers

PMID42644127
PMCPMC13505552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.